Years ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]
Read MoreAs I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]
Read MorePlus, President Trump abandoned his hope of re-opening the U.S. economy by Easter as cases surge to more than 143,000, Macy’s said it is furloughing the majority of its 130,000 employees, and Johnson & Johnson said it will begin human trails on its experimental COVID-19 vaccine by September.
Read MoreThis week the market has been trying to rebound and reclaim some of the territory it has lost since the broad indices hit a peak in mid-February. Looking at various news reports and opinions, I was interested to see one analyst that used the very graphic phrase, “catching a falling knife” to describe what he […]
Read MorePlus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.
Read MoreIf you’re like me, you can really only take so much of the daily commentary on any news media outlet that is entirely and completely fixed on COVID-19. That isn’t to minimize the importance of the crisis-level measures that, I think are appropriately being taken on a national scale to try to slow the spread […]
Read MoreBuy Target – $6.50 or better Sell Target – TradersPro Sell Signal Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste generated outside the hospital and health care facility settings; TakeAway Recovery System for […]
Read MorePlus, airlines could be in danger, and Regeneron and Sanofi are soon to begin human trials on a treatment for COVID-19.
Read MorePlus, Congress and the Trump Administration are nearing a coronavirus aid package, and the Fed began buying Treasurys.
Read MoreOne analyst says these 3 stocks could provide safety this year even amid coronavirus fears.
Read MoreBuy Target – $5.50 or better Sell Target – TradersPro Sell Signal AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company’s products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat […]
Read MorePlus, Italy announced a nation-wide lockdown in an attempt to slow the spread of the coronavirus, Saudi Arabia and Russia escalated their oil price war, and Dick’s Sporting Goods is removing guns from another 440 stores.
Read MorePlus, 30-year mortgage rates have fallen to their lowest level ever amid coronavirus fears, and an analyst says Gilead’s COVID-19 treatment only has a 50/50 chance, at best, of proving successful.
Read MorePlus, Pfizer announced it is initiating a program to screen antiviral drugs in its pipeline to identify possible treatments for the coronavirus, Target and Kohl’s reported earnings, and Thermo Fisher is buying Qiagen.
Read MorePlus, Tesla priced its secondary offering and issued a recall of its Model X SUVs in North America, and AstraZeneca posted plunging profits.
Read More